General description
INN
Abiraterone
Medicine type
Chemical agent
EML status history
First added in 2019
(TRS
1021)
for
Malignant neoplasms of prostate
Wikipedia
DrugBank
Recommendations
Section
Hormones and antihormones
- Oral > Solid: 250 mg; 500 mg
Indications